Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer

Breast cancer has the highest mortality and morbidity among women, especially in elderly women over 60 years old. Abnormal alternative splicing (AS) events are associated with the occurrence and development of geriatric breast cancer (GBC), yet strong evidence is lacking for the prognostic value of...

Full description

Bibliographic Details
Main Authors: Xin Li, Yaxuan Wang, Bingjie Li, Wang Ma
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/11/2/200
id doaj-67d353987f3c4a608a921c908f6fb386
record_format Article
spelling doaj-67d353987f3c4a608a921c908f6fb3862020-11-25T02:37:02ZengMDPI AGGenes2073-44252020-02-0111220010.3390/genes11020200genes11020200Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast CancerXin Li0Yaxuan Wang1Bingjie Li2Wang Ma3School of Medicine, Henan Polytechnic University, Jiaozuo 454150, Henan, ChinaSchool of Medicine, Henan Polytechnic University, Jiaozuo 454150, Henan, ChinaSchool of Medicine, Henan Polytechnic University, Jiaozuo 454150, Henan, ChinaSchool of Medicine, Henan Polytechnic University, Jiaozuo 454150, Henan, ChinaBreast cancer has the highest mortality and morbidity among women, especially in elderly women over 60 years old. Abnormal alternative splicing (AS) events are associated with the occurrence and development of geriatric breast cancer (GBC), yet strong evidence is lacking for the prognostic value of AS in GBC and the regulatory network of AS in GBC, which may highlight the mechanism through which AS contributes to GBC. In the present study, we obtained splicing event information (SpliceSeq) and clinical information for GBC from The Cancer Genome Atlas, and we constructed a GBC prognosis model based on AS events to predict the survival outcomes of GBC. Kaplan−Meier analysis was conducted to evaluate the predictive accuracy among different molecular subtypes of GBC. We conducted enrichment analysis and constructed a splicing network between AS and the splicing factor (SF) to examine the possible regulatory mechanisms of AS in GBC. We constructed eight prognostic signatures with very high statistical accuracy in predicting GBC survival outcomes from 45,421 AS events of 10,480 genes detected in 462 GBC patients; the prognostic model based on exon skip (ES) events had the highest accuracy, indicating its significant value in GBC prognosis. The constructed regulatory SF−AS network may explain the potential regulatory mechanism between SF and AS, which may be the mechanism through which AS events contribute to GBC survival outcomes. The findings confirm that AS events have a significant prognostic value in GBC, and we found a few effective prognostic signatures. We also hypothesized the mechanism underlying AS in GBC and discovered a potential regulatory mechanism between SF and AS.https://www.mdpi.com/2073-4425/11/2/200alternative splicinggeriatric breast cancersplicing factors
collection DOAJ
language English
format Article
sources DOAJ
author Xin Li
Yaxuan Wang
Bingjie Li
Wang Ma
spellingShingle Xin Li
Yaxuan Wang
Bingjie Li
Wang Ma
Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer
Genes
alternative splicing
geriatric breast cancer
splicing factors
author_facet Xin Li
Yaxuan Wang
Bingjie Li
Wang Ma
author_sort Xin Li
title Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer
title_short Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer
title_full Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer
title_fullStr Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer
title_full_unstemmed Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer
title_sort prognostic value and potential regulatory mechanism of alternative splicing in geriatric breast cancer
publisher MDPI AG
series Genes
issn 2073-4425
publishDate 2020-02-01
description Breast cancer has the highest mortality and morbidity among women, especially in elderly women over 60 years old. Abnormal alternative splicing (AS) events are associated with the occurrence and development of geriatric breast cancer (GBC), yet strong evidence is lacking for the prognostic value of AS in GBC and the regulatory network of AS in GBC, which may highlight the mechanism through which AS contributes to GBC. In the present study, we obtained splicing event information (SpliceSeq) and clinical information for GBC from The Cancer Genome Atlas, and we constructed a GBC prognosis model based on AS events to predict the survival outcomes of GBC. Kaplan−Meier analysis was conducted to evaluate the predictive accuracy among different molecular subtypes of GBC. We conducted enrichment analysis and constructed a splicing network between AS and the splicing factor (SF) to examine the possible regulatory mechanisms of AS in GBC. We constructed eight prognostic signatures with very high statistical accuracy in predicting GBC survival outcomes from 45,421 AS events of 10,480 genes detected in 462 GBC patients; the prognostic model based on exon skip (ES) events had the highest accuracy, indicating its significant value in GBC prognosis. The constructed regulatory SF−AS network may explain the potential regulatory mechanism between SF and AS, which may be the mechanism through which AS events contribute to GBC survival outcomes. The findings confirm that AS events have a significant prognostic value in GBC, and we found a few effective prognostic signatures. We also hypothesized the mechanism underlying AS in GBC and discovered a potential regulatory mechanism between SF and AS.
topic alternative splicing
geriatric breast cancer
splicing factors
url https://www.mdpi.com/2073-4425/11/2/200
work_keys_str_mv AT xinli prognosticvalueandpotentialregulatorymechanismofalternativesplicingingeriatricbreastcancer
AT yaxuanwang prognosticvalueandpotentialregulatorymechanismofalternativesplicingingeriatricbreastcancer
AT bingjieli prognosticvalueandpotentialregulatorymechanismofalternativesplicingingeriatricbreastcancer
AT wangma prognosticvalueandpotentialregulatorymechanismofalternativesplicingingeriatricbreastcancer
_version_ 1724797095199637504